Aminoratjadone

Front cover illustration for Chemical Science, depicting how the newly discovered nuclear export inhibitor aminoratjadone can act as an extracellular-targeted drug conjugate to disrupt cancer cells.

The research was done by the lab of Mark Brönstrup at Helmholtz Centre for Infection Research

Publication: The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates.
Philipp Klahn et al. Chemical Science